School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
Int J Mol Sci. 2022 Nov 24;23(23):14667. doi: 10.3390/ijms232314667.
Maintenance of the tightly regulated homeostatic environment of the brain is facilitated by the blood-brain barrier (BBB). P-glycoprotein (P-gp), an ATP-binding cassette transporter, is expressed on the luminal surface of the endothelial cells in the BBB, and actively exports a wide variety of substrates to limit exposure of the vulnerable brain environment to waste buildup and neurotoxic compounds. Downregulation of P-gp expression and activity at the BBB have been reported with ageing and in neurodegenerative diseases. Upregulation of P-gp at the BBB contributes to poor therapeutic outcomes due to altered pharmacokinetics of CNS-acting drugs. The regulation of P-gp is highly complex, but unravelling the mechanisms involved may help the development of novel and nuanced strategies to modulate P-gp expression for therapeutic benefit. This review summarises the current understanding of P-gp regulation in the brain, encompassing the transcriptional, post-transcriptional and post-translational mechanisms that have been identified to affect P-gp expression and transport activity.
血脑屏障(BBB)有助于维持大脑中严格调节的稳态环境。P-糖蛋白(P-gp)是一种 ATP 结合盒转运蛋白,表达于 BBB 内皮细胞的腔侧表面,可主动将多种底物输出,以限制易损的大脑环境接触废物堆积和神经毒性化合物。据报道,随着年龄的增长和神经退行性疾病的发生,BBB 上的 P-gp 表达和活性会下调。BBB 上 P-gp 的上调会导致中枢神经系统作用药物的药代动力学改变,从而导致治疗效果不佳。P-gp 的调节非常复杂,但阐明相关机制可能有助于开发新的、细致的策略来调节 P-gp 的表达,以实现治疗获益。本综述总结了目前对大脑中 P-gp 调节的理解,包括已确定的影响 P-gp 表达和转运活性的转录、转录后和翻译后机制。